Covenant Breaches and Default Triggers

Introduction

Covenant breaches are usually the first formal signal that a leveraged borrower has slipped into distress. Long before the company runs out of cash or hits a maturity wall, a covenant test, run quarterly off the company's compliance certificate, returns a number on the wrong side of a contractual line. The borrower is technically in default, the lender has the right to accelerate the debt, and the legal architecture of the credit agreement immediately reshapes the negotiation. For restructuring bankers, the covenant breach is the most common entry point into a new engagement: the company calls counsel, counsel calls the RX bank, and the diagnostic phase begins.

Understanding what covenants actually require, how the negotiation that follows a breach plays out, how the cross-default architecture cascades a single trip into a full capital-structure event, and how the cov-lite shift in the US leveraged loan market has changed the timing of all of this is central to thinking about distress. This article walks through the covenant categories, the EBITDA add-back fight that determines whether a covenant has actually broken, the equity-cure mechanics that buy borrowers a finite number of free passes, the breach-to-resolution sequence that follows, and the cross-default architecture that connects every instrument in the capital stack.

The first distinction is between covenants that the borrower must satisfy continuously and covenants that only apply when the borrower takes a specific action.

Maintenance Covenant

A financial covenant in a credit agreement that the borrower must satisfy at all times, typically tested quarterly off a compliance certificate signed by the CFO. Maintenance covenants commonly include a maximum leverage ratio (total debt to EBITDA), a minimum interest coverage ratio (EBITDA to interest expense), and a minimum fixed-charge coverage ratio. A failure to satisfy a maintenance covenant is an immediate event of default, giving the lender the right to accelerate the debt or demand other remedies. Maintenance covenants are common in revolving credit facilities and historically appeared in term loan B credit agreements; they are now rare in cov-lite institutional loans.

Incurrence covenants, by contrast, only apply when the borrower takes a specific action. A leveraged loan or high-yield bond indenture might allow the company to incur additional debt only if pro forma leverage stays below 6.5x, or might restrict dividends and restricted payments unless a fixed-charge coverage ratio test is met. The borrower can sit at 7.0x leverage indefinitely without breaching anything, as long as it does not try to incur more debt or distribute capital. Incurrence covenants matter for liability-management activity (an uptier exchange requires the company to clear specific incurrence tests) but do not, by themselves, give lenders an early-warning trigger to demand renegotiation.

The implication is that the legal architecture determines when a restructuring banker gets called. A company in a fully covenanted credit agreement that misses an EBITDA forecast in Q3 finds itself in default by mid-October, with lenders ready to negotiate amendments by November. The same company in a cov-lite agreement may operate at the same leverage for two more years, until the maturity wall arrives and the lender has nothing to accelerate against until then.

Three financial covenants account for the bulk of maintenance covenant breaches in practice. Each one tests a different dimension of credit health, and understanding the formula matters because the dispute often turns on the components rather than the headline ratio.

Real-world breaches almost always involve EBITDA. The numerator on the leverage ratio falls; the denominator on coverage ratios falls; both ratios move the wrong direction simultaneously. The single most common variant is the springing leverage covenant on revolving credit facilities, which only tests when utilization exceeds a defined threshold:

Trigger thresholds typically run 35-40%, meaning the test "springs" precisely at the moment the company is drawing down for liquidity reasons. Restructuring bankers often see the springing test as the first warning bell because it triggers on the same operational stress that caused the borrower to draw the revolver in the first place.

The maintenance-versus-incurrence distinction is mathematical, not just procedural. A maintenance covenant tests every quarter regardless of action; an incurrence covenant tests only when the borrower attempts a specific transaction:

The pro-forma ratio in an incurrence test treats the proposed transaction as if it had already closed, with the new debt added to the numerator and any synergy or earnings adjustments added to the denominator. Cov-lite credit agreements have no maintenance covenants, so the borrower can sit at any leverage level indefinitely as long as it does not trigger an incurrence test by taking a restricted action.

The EBITDA Add-Back Fight

The technical breach is whatever the credit agreement says, but the practical fight is over what counts as Covenant EBITDA. The definition of "Consolidated EBITDA" or "Covenant EBITDA" in the credit agreement governs which adjustments are permitted, and the gap between GAAP EBITDA and Covenant EBITDA is often the single most contested item in any quarterly compliance discussion. The walk from reported earnings to the covenant test typically takes the form:

Cov-lite documentation often allows generous add-backs (sometimes capped at 25% of base EBITDA but frequently with multiple uncapped categories), and 2024 academic research on add-back economics found that loans with very high cumulative add-back capacity exhibit measurably worse default and recovery outcomes when stress arrives. When the add-backs aggregate to 30-40% of GAAP EBITDA, the covenant test becomes a near-fiction. Restructuring bankers triaging a borderline situation start by stripping the add-backs and rebuilding Covenant EBITDA on a defensible basis; the gap between management's number and the rebuilt number is often the first clue that a deeper restructuring is coming.

When a sponsor-owned company comes close to a financial covenant breach, the credit agreement typically gives the sponsor a contractual right to cure the breach by injecting additional equity capital. The equity cure provision is one of the most commercially important features of a sponsor-backed credit agreement, and its mechanics shape how distressed sponsor situations actually play out.

Equity Cure

A contractual right in a credit agreement that allows a sponsor or other equity holder to cure a breach of a financial covenant by injecting additional equity capital into the borrower in an amount that, when added to Covenant EBITDA (or in some agreements, applied to reduce Net Debt), brings the relevant ratio back into compliance for the test period. Equity cure rights are heavily negotiated, capped both in dollar terms and frequency (typically three to four cures over the life of the loan, often not in consecutive quarters and not more than twice in any twelve-month period), and restricted as to use of the cure proceeds (typically prohibited from being applied to repay revolver borrowings).

In the EBITDA-add-back form of the cure, the contribution flows through the covenant test as:

The frequency caps that govern how many cures the sponsor can deploy combine three independent constraints, all of which must hold:

The cure multiplier is typically 1x (a dollar of equity buys a dollar of EBITDA add-back). Common frequency caps run 3 cures in any four-quarter window with a lifetime cap of 5, sometimes paired with a hard per-cure dollar cap. A sponsor that has already used 4 of 5 lifetime cures, or 2 of any 3 in the most recent 4-quarter window, is functionally out of cure capacity even if it has unlimited fund-level capital.

Equity cure rights have become standard in sponsor-backed leveraged loans: by 2023, more than 60% of broadly syndicated leveraged buyouts included equity cure language, up from approximately 45% in 2021. The mechanics matter for the restructuring banker because the cure history is one of the early signals of how the company arrived at distress.

A sponsor-owned company that has used three equity cures in the last 18 months is signaling several things at once:

Cure rights also have technical pitfalls. Most credit agreements require the cure equity to be applied either as an add-back to EBITDA (the more sponsor-friendly version) or as a reduction in Net Debt (the more lender-friendly version). The two approaches produce different headroom on the same dollar of equity, which is why the choice is one of the most negotiated points when the cure provision is being drafted. Some agreements limit how the cure can be deployed (prohibiting use to repay revolver borrowings, requiring the proceeds to be held as cash on the balance sheet for a defined period). Others include "deemed cure" provisions where the cure is automatically deemed to occur if the sponsor delivers a written commitment, even before the cash actually arrives, which can create timing fights when the equity does not fund as promised.

A breach gives the lender contractual remedies but does not, in practice, automatically lead to enforcement. The negotiation that follows runs through a familiar sequence, with each step adding cost and constraint until either the company stabilizes or the situation crystallizes into a comprehensive restructuring.

Amendment fees on covenant waivers vary materially. A clean first-time waiver in a sponsor-backed deal with a credible recovery path can clear at 25 basis points; a third waiver in 18 months on the same covenant in a stressed credit can run 100-200 basis points or more, plus equity warrants, plus interest rate step-ups, plus the cost of the financial advisor and counsel the lender requires the company to retain. The economic give-back compounds across cycles, which is why successive waivers are often described as "managing the decline" rather than fixing the underlying problem.

The single most consequential mechanic in a covenant breach is the cross-default architecture connecting the company's debt instruments. A breach in one credit agreement does not, by itself, send the company into bankruptcy. But virtually every credit agreement and bond indenture in a leveraged capital structure contains a cross-default or cross-acceleration provision that pulls a single breach into a multi-instrument event of default.

Cross-Default vs Cross-Acceleration

A cross-default clause provides that an event of default under one debt instrument is automatically an event of default under another. A cross-acceleration clause is narrower: it triggers only when the holders of the first instrument actually accelerate the debt in response to the default. Borrower-friendly documentation generally includes only cross-acceleration (giving the borrower time to cure or negotiate before the second-tier holders can act); lender-friendly documentation includes cross-default (any breach lights up the entire stack). Cross-default and cross-acceleration provisions are typically subject to a materiality threshold, so a small breach in a non-material instrument does not detonate the whole capital structure.

Cross-default provisions appear in approximately 90% of syndicated loan agreements. The materiality thresholds differ sharply by credit profile: investment-grade borrowers typically negotiate a materiality threshold around $25 million (only defaults on debt above that size trigger cross-default), while non-investment-grade leveraged borrowers usually face thresholds closer to $5 million. The threshold matters because most companies have multiple small debt instruments (capital leases, equipment finance, smaller revolvers, hedge agreements), and a low threshold means an isolated default on a peripheral instrument can light up the whole stack.

The implication is structural. A company with a revolving credit facility, a term loan B, and senior unsecured notes does not face three separate restructuring negotiations when its leverage ratio breaks. It faces one, because the revolver default has lit up cross-default provisions in the term loan and the indenture, and every creditor has a claim to renegotiate at the same time. Restructuring engagements therefore typically begin with capital-structure mapping (identifying every cross-default thread, every materiality threshold, every grace period, every disputed-obligation carve-out) before any individual lender negotiation begins. Skipping this mapping is one of the most common errors first-time RX advisors make: it leads to negotiating with the revolver lenders for two weeks before discovering that the bond indenture has already been triggered and the bondholder advisors have been preparing their own response in parallel.

The single most consequential change in covenant architecture over the last fifteen years is the cov-lite shift in the US leveraged loan market. As of year-end 2024, covenant-lite loans represented roughly 91% of outstanding US leveraged loans, with 93% of all institutional loans issued during 2024 priced as cov-lite. The terminology, explained at length here, means that institutional term loans now carry only incurrence covenants in most cases, eliminating the maintenance-covenant trigger that historically pulled lenders into early conversations with deteriorating borrowers.

The downstream effects matter for restructuring practice in three ways:

Default rates reflect the timing shift. The Morningstar LSTA US Leveraged Loan Index combined default rate (including distressed liability-management exchanges) peaked at 4.70% in December 2024, the highest reading since the end of 2020, and eased to 4.4% by August 2025. Cov-lite has not eliminated default; it has compressed defaults into a sharper, more concentrated wave at maturity rather than a steady drumbeat through the life of the loan.

The private credit market presents a partial counterweight. Direct lending fund covenants are typically tighter than broadly syndicated loan covenants (single-lender or club deals can negotiate documentation in ways the institutional market cannot), with maintenance covenants more common and add-back caps more conservative. The Fitch US private credit default rate climbed from approximately 0% in 2022 to roughly 5.7% by early 2025, demonstrating that even tighter documentation does not prevent default when the underlying business deteriorates; it just changes the timing of when lenders are pulled into the negotiation.

For a restructuring banker triaging a new engagement, the covenant architecture is the first thing to map. A fully covenanted credit agreement with a maintenance leverage test and a tight cross-default web means the company has a near-term decision point and that the lender group has real leverage. A cov-lite term loan B with an incurrence-only structure and a back-loaded maturity means the company has more time but fewer guardrails, and that the most consequential negotiation is likely to be at refinancing rather than any covenant trigger. A sponsor-backed deal with two unused equity cures and a full revolver in springing mode is in a different phase than a non-sponsor deal that has already used four cures and amended its maintenance covenant twice.

Bankers who can read a credit agreement at speed (the cross-default thresholds, the EBITDA add-backs, the cure rights, the equity-cure mechanics, the J.Crew and Serta blockers in newer documents, the unrestricted-subsidiary baskets that enable LMT activity) bring an analytical edge that compounds across the engagement. The breach is the trigger; the document is the playing field; the negotiation that follows is shaped by every comma in the credit agreement.